The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization Most people hear not FDA approved and immediately think unsafe or ineffective but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Is BPC 157 Legal? Understanding Its Status and Implications